JP2014524475A5 - - Google Patents

Download PDF

Info

Publication number
JP2014524475A5
JP2014524475A5 JP2014527282A JP2014527282A JP2014524475A5 JP 2014524475 A5 JP2014524475 A5 JP 2014524475A5 JP 2014527282 A JP2014527282 A JP 2014527282A JP 2014527282 A JP2014527282 A JP 2014527282A JP 2014524475 A5 JP2014524475 A5 JP 2014524475A5
Authority
JP
Japan
Prior art keywords
amino
pyridazin
phenyl
oxo
dihydropyrimido
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014527282A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014524475A (ja
JP5993010B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/051980 external-priority patent/WO2013028818A1/en
Publication of JP2014524475A publication Critical patent/JP2014524475A/ja
Publication of JP2014524475A5 publication Critical patent/JP2014524475A5/ja
Application granted granted Critical
Publication of JP5993010B2 publication Critical patent/JP5993010B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014527282A 2011-08-23 2012-08-23 ピリミド−ピリダジノン化合物及びその使用 Active JP5993010B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161526525P 2011-08-23 2011-08-23
US61/526,525 2011-08-23
PCT/US2012/051980 WO2013028818A1 (en) 2011-08-23 2012-08-23 Pyrimido- pyridazinone compounds and use thereof

Publications (3)

Publication Number Publication Date
JP2014524475A JP2014524475A (ja) 2014-09-22
JP2014524475A5 true JP2014524475A5 (cg-RX-API-DMAC10.html) 2015-10-15
JP5993010B2 JP5993010B2 (ja) 2016-09-14

Family

ID=46829884

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014527282A Active JP5993010B2 (ja) 2011-08-23 2012-08-23 ピリミド−ピリダジノン化合物及びその使用

Country Status (14)

Country Link
US (5) US8729079B2 (cg-RX-API-DMAC10.html)
EP (4) EP3404029A3 (cg-RX-API-DMAC10.html)
JP (1) JP5993010B2 (cg-RX-API-DMAC10.html)
CN (2) CN108707151B (cg-RX-API-DMAC10.html)
BR (1) BR112014003981A2 (cg-RX-API-DMAC10.html)
CA (1) CA2846187A1 (cg-RX-API-DMAC10.html)
DK (2) DK2748166T3 (cg-RX-API-DMAC10.html)
ES (2) ES2690971T3 (cg-RX-API-DMAC10.html)
FI (1) FI3392252T3 (cg-RX-API-DMAC10.html)
HU (1) HUE065564T2 (cg-RX-API-DMAC10.html)
IL (1) IL231082A (cg-RX-API-DMAC10.html)
MX (1) MX361458B (cg-RX-API-DMAC10.html)
PL (1) PL2748166T3 (cg-RX-API-DMAC10.html)
WO (1) WO2013028818A1 (cg-RX-API-DMAC10.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2748166T3 (en) * 2011-08-23 2018-10-29 Asana Biosciences Llc PYRIMIDO-PYRIDAZINON COMPOUNDS AND USE THEREOF
AR106830A1 (es) * 2015-12-04 2018-02-21 Asana Biosciences Llc Usos de piridazinonas para tratar el cáncer
WO2018187294A1 (en) * 2017-04-03 2018-10-11 Asana Biosciences, Llc Pyrimido-pyridazinone compound combinations, methods, kits and formulations thereof
CN118105392A (zh) * 2017-04-28 2024-05-31 自由生物有限公司 治疗特应性皮炎以及提高活性药物成分稳定性的制剂、方法、试剂盒和剂型
CN111961035B (zh) * 2019-05-20 2022-11-01 南京科技职业学院 一类含有羟基异喹啉类结构的化合物、药物组合物以及其应用
WO2021027943A1 (zh) * 2019-08-14 2021-02-18 正大天晴药业集团南京顺欣制药有限公司 哒嗪酮并嘧啶类衍生物及其医药用途
CN113583026B (zh) * 2020-04-30 2024-06-14 杭州英创医药科技有限公司 一类含有稠合三环结构的化合物
WO2022002118A1 (zh) * 2020-07-01 2022-01-06 四川海思科制药有限公司 一种并环杂环衍生物及其在医药上的应用
EP4452416A1 (en) * 2021-12-22 2024-10-30 The Regents Of The University Of California Covalently binding inhibitors of g12s, g12d and/or g12e mutants of k-ras gtpase
CA3244694A1 (en) 2022-02-23 2023-08-31 Assia Chemical Industries Ltd. SOLID FORMS OF GUSACITINIB
WO2023192989A2 (en) * 2022-04-01 2023-10-05 Azkarra Therapeutics, Inc. Phthalazinone compounds as parp7 inhibitors
TW202510870A (zh) 2023-07-27 2025-03-16 美商自由生物有限公司 Jak/syk抑制劑之組合物及固體形式
WO2025020171A1 (en) * 2023-07-27 2025-01-30 Libertas Bio, Inc. Crystalline forms of a jak/syk inhibitor

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE756508A (fr) * 1969-09-24 1971-03-01 Takeda Chemical Industries Ltd Derives de pyrimidopyridazine
CA1004223A (en) * 1972-05-12 1977-01-25 Theodor Denzel Amino derivatives of pyrido(2,3-d)pyridazine carboxylic acids and esters
JPS4948695U (cg-RX-API-DMAC10.html) 1972-07-29 1974-04-27
JPS50101387A (cg-RX-API-DMAC10.html) * 1974-01-16 1975-08-11
CA1052046A (en) 1974-01-21 1979-04-03 American Cyanamid Company Unsymmetrically substituted 1,4-dioxane-2,5-diones
US5369086A (en) 1993-04-28 1994-11-29 Zeneca Limited N-benzotriazoles
IL112249A (en) 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
JPH0948695A (ja) 1995-08-02 1997-02-18 Toshiba Ceramics Co Ltd シリコン単結晶の製造方法
AU3180999A (en) 1998-02-25 1999-09-15 Pharmacia & Upjohn Company Substituted aminomethyl isoxazoline derivatives useful as antimicrobials
HU227453B1 (en) 1998-11-10 2011-06-28 Janssen Pharmaceutica Nv Hiv replication inhibiting pyrimidines, and pharmaceutical compositions containing them
DE60132607T2 (de) * 2000-09-22 2009-01-29 N.V. Organon Bicyclische heteroaromatische verbindungen
MXPA03009938A (es) 2001-04-30 2005-09-07 Glaxo Group Ltd Pirimidinas fusionadas como antagonistas del factor liberador de corticotropina.
WO2003075828A2 (en) 2002-03-11 2003-09-18 Zetiq Technologies Ltd. Compounds useful in the treatment of cancer
RS51752B (sr) 2002-07-29 2011-12-31 Rigel Pharmaceuticals Metode tretiranja i prevencije autoimunih oboljenja jedinjenjima 2,4-pirimidindiamina
KR20050122220A (ko) 2003-03-25 2005-12-28 다케다 샌디에고, 인코포레이티드 디펩티딜 펩티다제 억제제
RS53109B (sr) 2003-07-30 2014-06-30 Rigel Pharmaceuticals Inc. Jedinjenja 2,4 pirimidindiamina za upotrebu u tretmanu ili prevenciji autoimunih bolesti
JPWO2005080377A1 (ja) 2004-02-20 2007-10-25 キリンホールディングス株式会社 TGFβ阻害活性を有する化合物およびそれを含んでなる医薬組成物
US8575342B2 (en) 2004-09-30 2013-11-05 Tibotech Pharmaceuticals Ltd. HIV inhibiting 5-heterocyclyl pyrimidines
CN102861019B (zh) 2004-12-24 2016-05-25 诺华股份有限公司 治疗或预防神经性疼痛的药物
DK1869037T3 (da) 2005-03-25 2011-10-24 Tibotec Pharm Ltd Heterobicykliske inhibitorer af HVC
WO2006105063A1 (en) 2005-03-25 2006-10-05 Scios Inc. Heterobicylic inhibitors of tgfbeta
EA200702377A1 (ru) 2005-04-29 2008-02-28 Янссен Фармацевтика Н.В. Производные бензотриазола в качестве антагонистов каннабиноидного рецептора
US20090182140A1 (en) * 2005-12-02 2009-07-16 Mitsubishi Tanabe Pharma Corporation Alicyclic Heterocyclic Compound
WO2007082131A1 (en) 2006-01-09 2007-07-19 Bristol-Myers Squibb Company Process for the preparation of hydroxy substituted heterocycles
WO2007125405A2 (en) 2006-05-01 2007-11-08 Pfizer Products Inc. Substituted 2-amino-fused heterocyclic compounds
GB0625196D0 (en) 2006-12-18 2007-01-24 7Tm Pharma As Modulators of cannabinoid receptor
MY165570A (en) * 2006-12-28 2018-04-05 Abbvie Inc Inhibitors of poly (adp-ribose) polymerase
CN101679308B (zh) 2007-03-14 2014-05-07 埃克塞里艾克西斯公司 Hedgehog途径抑制剂
TW200942537A (en) 2008-02-01 2009-10-16 Irm Llc Compounds and compositions as kinase inhibitors
CN102227422A (zh) 2008-09-30 2011-10-26 阿斯利康(瑞典)有限公司 杂环jak激酶抑制剂
TW201016676A (en) 2008-10-03 2010-05-01 Astrazeneca Ab Heterocyclic derivatives and methods of use thereof
CN102186825A (zh) 2008-10-21 2011-09-14 麦它波莱克斯股份有限公司 芳基gpr120受体激动剂和其用途
KR101690358B1 (ko) * 2009-10-29 2017-01-09 제노스코 키나아제 억제제
US20110152243A1 (en) * 2009-12-23 2011-06-23 Abbott Laboratories Novel thienopyrrole compounds
US8440662B2 (en) 2010-10-31 2013-05-14 Endo Pharmaceuticals, Inc. Substituted quinazoline and pyrido-pyrimidine derivatives
DK2748166T3 (en) * 2011-08-23 2018-10-29 Asana Biosciences Llc PYRIMIDO-PYRIDAZINON COMPOUNDS AND USE THEREOF
WO2014022728A1 (en) 2012-08-02 2014-02-06 Endo Pharmaceuticals, Inc Substituted 5 - (quinazolin - 2 - yl) pyrimidin- 2 -amine derivatives useful as pi3k/mtor inhibitors for the treatment of cancer
AR106830A1 (es) * 2015-12-04 2018-02-21 Asana Biosciences Llc Usos de piridazinonas para tratar el cáncer
CN118105392A (zh) * 2017-04-28 2024-05-31 自由生物有限公司 治疗特应性皮炎以及提高活性药物成分稳定性的制剂、方法、试剂盒和剂型

Similar Documents

Publication Publication Date Title
JP2014524475A5 (cg-RX-API-DMAC10.html)
ES2922174T3 (es) Compuestos de indol sustituidos con amida útiles como inhibidores de TLR
JP2019517596A5 (cg-RX-API-DMAC10.html)
AU2016352813B2 (en) Novel pyrazolo pyrimidine derivatives
AU2013210438B2 (en) Pyrazine carboxamide compound
RU2018124289A (ru) Применения пиримидо-пиридазинонов для лечения рака
ES2946274T3 (es) Inhibidores de TRPC6
JP7366994B2 (ja) 自己免疫疾患治療用の新規ピペラジン化合物
KR20230024251A (ko) 신규 plk1 분해 유도 화합물
AU2015304883A1 (en) Aminopyrimidinyl compounds as JAK inhibitors
RU2014154397A (ru) Соединения тетрагидропиразолопиримидина
EP2925322A1 (en) Inhibitors of the renal outer medullary potassium channel
KR20140138851A (ko) 류코트리엔 생성 억제를 위해 기타 활성제와 병용된 벤조디옥산
KR20150127721A (ko) 디하이드로피리다진-3,5-디온 유도체
KR102646850B1 (ko) 안드로겐 수용체 분해용 화합물 및 이들의 의약 용도
WO2024059808A1 (en) Wee1 inhibitors and methods for treating cancer
RU2666894C2 (ru) Производные пиперидинмочевины
JP2024009891A (ja) T型カルシウムチャネル阻害剤
RU2472781C2 (ru) Новые соединения 707 и их применение
RU2006146621A (ru) Производные нафталина, пригодные в качестве лигандов рецепторов 3 гистамина
KR20230159524A (ko) Bcl-2 저해제로서 ((3-나이트로페닐)설포닐)아세트아마이드를 갖는 화합물
JP2022081710A (ja) 関節リウマチを治療するためのt型カルシウムチャネル阻害剤の使用
AU2023330130A1 (en) Compounds and methods for modulating her2
AU2018276190B2 (en) 5,6-fused-bicyclic compounds and compositions for the treatment of parasitic diseases
CA3235328A1 (en) Covalent egfr inhibitors and methods of use thereof